Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wilson I Gonsalves

Showing results (1-10 of 211) with videos related to

Pageof 22
Sort By:
Acta Haematologica|June 8, 2020
Ageism in the t(11;14) Subtype of Multiple MyelomaWilson I Gonsalves, Harsh Parmar
Gastrointestinal Cancer Research : GCR|February 28, 2012
Waiting in line for cancer treatments?Wilson I Gonsalves, Axel Grothey
Acta Haematologica|February 7, 2018
Second Autologous Hematopoietic Stem Cell Transplant as Salvage Therapy for Relapsed Multiple Myeloma: A Global Treatment Option for Eligible PatientsWilson I Gonsalves, Ankit Kansagra
The Lancet. Haematology|January 15, 2022
Melflufen for multiple myeloma: a promise unfulfilled?Prashant Kapoor, Wilson I Gonsalves
Oncotarget|February 6, 2019
Plasmacytomas: many faces of one disease, or many diseases with one face?Gaurav Goyal, Wilson I Gonsalves
Blood|April 4, 2020
Of lions, shar-pei, and doughnuts: a tale retoldPrashant Kapoor, Wilson I Gonsalves
Cancer Treatment and Research Communications|July 25, 2022
Evolving progress in the management of malignant plasma cell disordersEzgi Atilgan, Wilson I Gonsalves
Cancer Treatment and Research Communications|September 23, 2021
Current diagnosis, risk stratification and treatment paradigms in newly diagnosed multiple myelomaGayathri Ravi, Wilson I Gonsalves
Leukemia & Lymphoma|December 7, 2013
Bortezomib-based combination regimens in myeloma: more is not necessarily betterWilson I Gonsalves, Morie A Gertz
Annals of Internal Medicine|December 12, 2022
Monoclonal Gammopathy of Undetermined SignificanceWilson I Gonsalves, S Vincent Rajkumar
Pageof 22

Showing results (1-10 of 211) with videos related to

Sort By:
Pageof 22
Acta Haematologica|June 8, 2020
Ageism in the t(11;14) Subtype of Multiple MyelomaWilson I Gonsalves, Harsh Parmar
Gastrointestinal Cancer Research : GCR|February 28, 2012
Waiting in line for cancer treatments?Wilson I Gonsalves, Axel Grothey
Acta Haematologica|February 7, 2018
Second Autologous Hematopoietic Stem Cell Transplant as Salvage Therapy for Relapsed Multiple Myeloma: A Global Treatment Option for Eligible PatientsWilson I Gonsalves, Ankit Kansagra
The Lancet. Haematology|January 15, 2022
Melflufen for multiple myeloma: a promise unfulfilled?Prashant Kapoor, Wilson I Gonsalves
Oncotarget|February 6, 2019
Plasmacytomas: many faces of one disease, or many diseases with one face?Gaurav Goyal, Wilson I Gonsalves
Blood|April 4, 2020
Of lions, shar-pei, and doughnuts: a tale retoldPrashant Kapoor, Wilson I Gonsalves
Cancer Treatment and Research Communications|July 25, 2022
Evolving progress in the management of malignant plasma cell disordersEzgi Atilgan, Wilson I Gonsalves
Cancer Treatment and Research Communications|September 23, 2021
Current diagnosis, risk stratification and treatment paradigms in newly diagnosed multiple myelomaGayathri Ravi, Wilson I Gonsalves
Leukemia & Lymphoma|December 7, 2013
Bortezomib-based combination regimens in myeloma: more is not necessarily betterWilson I Gonsalves, Morie A Gertz
Annals of Internal Medicine|December 12, 2022
Monoclonal Gammopathy of Undetermined SignificanceWilson I Gonsalves, S Vincent Rajkumar
Pageof 22